• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Vectura Group Hits GBP9 Million Royalty Target on Glaxo's Ellipta Products

    Vectura Group Hits GBP9 Million Royalty Target on Glaxo's Ellipta Products

  2. LONDON MARKETS: FTSE 100 In Holding Pattern, But Rio Tinto Roars Higher After Earnings

    LONDON MARKETS: FTSE 100 In Holding Pattern, But Rio Tinto Roars Higher After Earnings

  3. FTSE 100 in holding pattern, but Rio Tinto roars higher after earnings

    FTSE 100 in holding pattern, but Rio Tinto roars higher after earnings

  4. LONDON MARKETS: FTSE 100 In Holding Pattern, But Rio Tinto Rises After Earnings

    LONDON MARKETS: FTSE 100 In Holding Pattern, But Rio Tinto Rises After Earnings

  5. UPDATE: FTSE 100 in holding pattern, but Rio Tinto rises after earnings

    UPDATE: FTSE 100 in holding pattern, but Rio Tinto rises after earnings

  6. GlaxoSmithKline Swung to Profit in Fourth Quarter, Helped by Weak Pound

    GlaxoSmithKline Swung to Profit in Fourth Quarter, Helped by Weak Pound

  7. GlaxoSmithKline Swung to Profit in Fourth Quarter, Helped by Weak Pound -- 2nd Update

    GlaxoSmithKline Swung to Profit in Fourth Quarter, Helped by Weak Pound -- 2nd Update

  8. Bacterial Pneumonia - Pipeline Review, H2 2016 - Research and Markets

    Bacterial Pneumonia - Pipeline Review, H2 2016 - Research and Markets

  9. Drug Delivery Technology Market by Route of Administration, Facility of Use & Region - Global Forecast to 2021 - Research and Markets

    Drug Delivery Technology Market by Route of Administration, Facility of Use & Region - Global Forecast to 2021 - Research and Markets

  10. Acute Lung Injury - Pipeline Review, H2 2016 - Research and Markets

    Acute Lung Injury - Pipeline Review, H2 2016 - Research and Markets

123

©2017 Morningstar Advisor. All right reserved.